Gilead slashing prices of top-selling hepatitis C drugs

In this video

Share

Gilead slashing prices of top-selling hepatitis C drugs

CNBC's Meg Tirell reports on Gilead's plans to introduce authorized generic versions of its top-selling hepatitis C drugs.
02:01
Tue, Sep 25 20184:37 PM EDT